Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Friday sept 1 trading

<< Previous

Bullboard Posts

Next >>

Post by digital130on Sep 04, 2023 11:30am

172 Views

Post# 35618750

Friday sept 1 trading

During a half hour period greeline purchased 65K shares from 1 anonymous.

Biggest sale since stock hit 1.25 to 1.50 area prior to dejardins dumping.

Not even close to what i am looking for.

Watch the bots, they dont care about retailers. Either do insiders until they get there cheap shares.

Goodluck

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant